Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2007-04-23

Clinical Trial Update: Use of Arimidex and Zoladex as Pretreatment to IVF in Women With Ovarian Endometriosis [Phase 4]

View source ↗

Summary

Phase 4 trial update on using Arimidex (anastrozole) and Zoladex (goserelin) as pretreatment before IVF in women with ovarian endometriosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ARIMIDEX (anastrozole)
  • Zoladex (goserelin)

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Endometriosis | Phase 4 | Status: COMPLETED